New diabetes pill takes on popular drug in Head-to-Head trial
NCT ID NCT06415773
First seen Jun 27, 2026 · Last updated Aug 04, 2026 · Updated 2 times
Summary
This study tested a new drug called HTD1801 (berberine ursodeoxycholate) against the standard diabetes drug dapagliflozin in 367 adults with type 2 diabetes whose blood sugar was not well controlled by metformin alone. The main goal was to see how well HTD1801 lowers blood sugar levels over 24 weeks. The trial is complete, but results have not yet been shared.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- berberine ursodeoxycholate (HTD1801)
- What this could lead to
- If successful, HTD1801 could offer a new oral option for managing blood sugar in people with type 2 diabetes.
- What could go wrong
- This is a completed Phase 3 trial, but results are not yet published. It compares against an existing drug, so it may not prove superior or may have side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for T2DM (TYPE 2 DIABETES MELLITUS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Affiliated Hospital of Jiangsu University
Zhenjiang, China
-
Affiliated Hospital of Nantong University
Nantong, China
-
Beijing Pinggu Hospital
Beijing, China
-
Binzhou Medical University Hospital
Binzhou, China
-
Bishan Hospital of Chongqing
Chongqing, China
-
Handan First Hospital
Handan, China
-
Hebei Petro China Central Hospital
Langfang, China
-
Huadong Hospital Affiliated to Fudan University
Shanghai, China
-
Huanggang Central Hospital
Huanggang, China
-
Huangshi Central Hospital
Huangshi, China
-
Huizhou Municipal Central Hospital
Huizhou, China
-
Jilin Province FAW General Hospital
Changchun, China
-
Jincheng General Hospital
Jincheng, China
-
Liaocheng People's Hospital
Liaocheng, China
-
Luoyang Third People's Hospital
Luoyang, China
-
Nanjing Drum Tower Hospital - The Affiliated Hospital of Nanjing University Medical School
Nanjing, China
-
Panjin Liaohe Oilfield GEM Flower Hospital
Panjin, China
-
Peking University People's Hospital
Beijing, China
-
People's Hospital of Deyang City
Deyang, China
-
Pingxiang People's Hospital
Pingxiang, China
-
Sanmenxia Central Hospital
Sanmenxia, China
-
Shandong Guoxinyiyang Group Zaozhuang Central Hospital
Zaozhuang, China
-
Shanghai Sixth People's Hospital
Shanghai, China
-
Shengjing Hospital of China Medical University
Shenyang, China
-
The Central Hospital of Xiangtan
Xiangtan, China
-
The First Affiliated Hospital of Henan University of Science & Technology (Jinghua)
Luoyang, China
-
The First Affiliated Hospital of Henan University of Science & Technology (Kaiyuan)
Luoyang, China
-
The First Affiliated Hospital of Nanchang University
Nanchang, China
-
The First Affiliated Hospital of Nanyang Medical College
Nanyang, China
-
The First Affiliated Hospital of Xi'an Jiaotong University
Xi'an, China
-
The First Hospital of Changsha City
Changsha, China
-
The First Hospital of Qiqihar
Qiqihar, China
-
The First People's Hospital of Changde City
Changde, China
-
The First People's Hospital of Xiangtan City
Xiangtan, China
-
The Fourth Hospital of Changsha
Changsha, China
-
The Fourth Hospital of Harbin Medical University
Harbin, China
-
The People's Hospital of Liaoning Province
Shenyang, China
-
The Second Affiliated Hospital of Nanchang University
Nanchang, China
-
The Second Affiliated Hospital of Nanjing Medical University
Nanjing, China
-
The Second Affiliated Hospital of Xi'an Jiaotong University
Xi'an, China
-
The Second Affiliated Hospital of Zhengzhou University
Zhengzhou, China
-
The Second Hospital of Jilin University
Changchun, China
-
The Second People's Hospital of Huai'an
Huai'an, China
-
The Second People's Hospital of Lianyungang
Lianyungang, China
-
The Second People's Hospital of Yibin
Yibin, China
-
The Second Xiangya Hospital of Central South University
Changsha, China
-
The Third Xiangya Hospital of Central South University
Changsha, China
-
Wuhan Third Hospital
Wuhan, China
-
Xianyang Hospital of Yan'an University
Xianyang, China
-
Xuzhou Cancer Hospital
Xuzhou, China
-
Yiyang Central Hospital
Yiyang, China
-
Yueyang People's Hospital
Yueyang, China
-
Zhumadian Central Hospital
Zhumadian, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can an Anti-Inflammatory diet tame type 2 diabetes?
- New diabetes combo pill aims to beat single drugs in major trial
- New combo therapy aims to improve diabetes management
- New triple therapy aims to protect kidneys in diabetes patients
- New combo diabetes pill tested in healthy volunteers
- New diabetes pill put to the test: does food change how it works?